Review of health risks and organ damage from synthetic cannabinoids

Synthetic cannabinoids can damage the brain, heart, kidneys, and liver through CB1/CB2 receptor activation and non-cannabinoid targets, producing effects far more dangerous than natural cannabis.

Alzu'bi, Ayman et al.·European journal of medical research·2024·Moderate Evidencenarrative review
RTHC-05078Narrative reviewModerate Evidence2024RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
narrative review
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

Synthetic cannabinoids produce multisystem toxicity through CB1R and CB2R activation plus non-cannabinoid targets (GPR55, GPR18, PPARs, TRPV1). Downstream effects include oxidative stress, inflammation, and apoptosis in neurological, cardiovascular, renal, and hepatic systems.

Key Numbers

SC toxicity mediated by CB1R, CB2R, and non-cannabinoid targets including GPR55, GPR18, PPARs, and TRPV1. Effects documented across neurological, cardiovascular, renal, and hepatic systems.

How They Did This

Narrative review of published literature on synthetic cannabinoid health effects, organized by organ system and molecular mechanism of toxicity.

Why This Research Matters

Synthetic cannabinoids remain widely available despite bans and cause disproportionate emergency department visits relative to their use rates. Understanding multi-organ toxicity mechanisms helps clinicians recognize and treat exposures.

The Bigger Picture

While natural cannabis primarily activates CB1 as a partial agonist, many synthetic cannabinoids are full agonists with much higher potency and affinity. This pharmacological difference explains why synthetic cannabinoids produce emergency presentations rarely seen with natural cannabis.

What This Study Doesn't Tell Us

Review-level evidence with heterogeneous case reports and preclinical studies. Many synthetic cannabinoid variants exist with different toxicity profiles. Dose-response relationships are poorly characterized.

Questions This Raises

  • ?Can clinicians distinguish synthetic cannabinoid toxicity from natural cannabis effects in emergency settings?
  • ?Are there effective antidotes for acute synthetic cannabinoid poisoning?

Trust & Context

Key Stat:
Multi-organ toxicity via CB1, CB2, and beyond
Evidence Grade:
Comprehensive review synthesizing case reports and preclinical data, but limited by heterogeneous evidence quality.
Study Age:
2024 review of synthetic cannabinoid toxicity literature
Original Title:
The synthetic cannabinoids menace: a review of health risks and toxicity.
Published In:
European journal of medical research, 29(1), 49 (2024)
Database ID:
RTHC-05078

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

Why are synthetic cannabinoids more dangerous than natural cannabis?

Many synthetic cannabinoids are full agonists at CB1 receptors with much higher potency than THC, which is only a partial agonist. They also activate non-cannabinoid targets. This produces more severe effects across multiple organ systems.

What organs can synthetic cannabinoids damage?

The review documented toxicity across neurological (seizures, psychosis, stroke), cardiovascular (arrhythmias, myocardial infarction), renal (acute kidney injury), and hepatic (liver damage) systems.

Read More on RethinkTHC

Cite This Study

RTHC-05078·https://rethinkthc.com/research/RTHC-05078

APA

Alzu'bi, Ayman; Almahasneh, Fatimah; Khasawneh, Ramada; Abu-El-Rub, Ejlal; Baker, Worood Bani; Al-Zoubi, Raed M. (2024). The synthetic cannabinoids menace: a review of health risks and toxicity.. European journal of medical research, 29(1), 49. https://doi.org/10.1186/s40001-023-01443-6

MLA

Alzu'bi, Ayman, et al. "The synthetic cannabinoids menace: a review of health risks and toxicity.." European journal of medical research, 2024. https://doi.org/10.1186/s40001-023-01443-6

RethinkTHC

RethinkTHC Research Database. "The synthetic cannabinoids menace: a review of health risks ..." RTHC-05078. Retrieved from https://rethinkthc.com/research/alzu-bi-2024-the-synthetic-cannabinoids-menace

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.